Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.

[Mesoblast] MESOBLAST LIMITED : MSB ASX NEW DIRECTOR - 10 MAY 2012

Started by ImmInst , May 10 2012 02:23 AM

Please log in to reply

252 replies to this topic

#1 ImmInst

Admin, Director robot
2,350 posts
72 ₮

Posted 10 May 2012 - 02:23 AM

MESOBLAST LIMITED : MSB ASX NEW DIRECTOR - 10 MAY 2012
4-traders - 2 hours ago

NEW TEVA REPRESENTATIVE JOINS MESOBLAST BOARD OF DIRECTORS Melbourne, Australia; 10 May 2012: Global regenerative medicine company Mesoblast Limited (ASX: MSB) today announced the appointment of Dr Ben-Zion Weiner, Special Adviser to the CEO of Teva ...

View the full article

#2 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 10 May 2012 - 10:02 AM

New Teva Representative Joins Mesoblast Board of Directors
MarketWatch (press release) - 1 hour ago

MELBOURNE, Australia, May 10, 2012 /PRNewswire via COMTEX/ -- Global regenerative medicine company Mesoblast Limited (asx:MSB) today announced the appointment of Dr Ben-Zion Weiner, Special Adviser to the CEO of Teva Pharmaceutical Industries Ltd, ...

MESOBLAST LIMITED : MSB ASX NEW DIRECTOR - 10 MAY 2012 - 4-traders

View the full article

#3 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 10 May 2012 - 08:02 PM

Aastrom Biosciences Reports First Quarter 2012 Financial Results
MarketWatch (press release) - 1 hour ago

ANN ARBOR, Mich., May 10, 2012 (GlobeNewswire via COMTEX) -- Aastrom Biosciences, Inc. (UTD:ASTM) , the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today reported ...

View the full article

#4 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 10 May 2012 - 10:02 PM

BioTime Announces First Quarter 2012 Financial Results and Recent Corporate ...
Reuters - 48 minutes ago

Alameda, Calif., May 10, 2012 - BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the first quarter ended March 31, ...

View the full article

#5 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 01:55 PM

Teva Representative Joins Mesoblast's Board of Directors
BiotechStockTrader.com - 2 hours ago

Global regenerative medicine company Mesoblast Limited (asx:MSB) today announced the appointment of Dr Ben-Zion Weiner, Special Adviser to the CEO of Teva Pharmaceutical Industries Ltd, as a non-executive Director of Mesoblast, effective immediately.

MESOBLAST LIMITED : MSB ASX NEW DIRECTOR - 10 MAY 2012 - 4-traders

View the full article

#6 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 06:37 PM

BioTime (NYSE AMEX: BTX) Q1/12 Results and Highlights
Proactive Investors USA & Canada - 1 hour ago

Net loss was $5M or $0.10 per share, compared to a net loss of $3.4M or $0.07 per share for Q1/11. Q1/12 total revenue (including royalties from product sales and other revenue, revenue recognition of deferred license fees and grant income), ...

View the full article

#7 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 06:45 PM

RegMed Competitive and Market Intelligence 5/11/12, stocks mixed, sector ...
Proactive Investors USA & Canada - 3 hours ago

Mid-Day Market Commentary: Stocks extended their gains Friday, thanks to a better-than-expected consumer sentiment report. The CBOE Volatility Index slipped below 19.

View the full article

#8 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 12 May 2012 - 01:12 AM

Oppenheimer Gives Market Perform Rating to Aastrom Biosciences (ASTM)
Junction Report - 9 minutes ago

Aastrom Biosciences (NASDAQ: ASTM)'s stock had its â€œmarket performâ€ rating reiterated by equities research analysts at Oppenheimer (NYSE: OPY) in a research note issued to investors on Friday.

View the full article

#9 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 11:29 PM

Oppenheimer Reiterates Perform Rating for Aastrom Biosciences
Benzinga - 1 hour ago

By Dwight Einhorn In a company update published earlier today, Oppenheimer Holdings reiterated its Perform rating for Aastrom Biosciences, Inc. (NASDAQ: ASTM), but did not name a price target.

View the full article

#10 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 12 May 2012 - 03:11 AM

Equities Research Analysts' Ratings Reiterations for May, 11st (AGCO, ARX ...
Junction Report - 1 hour ago

AGCO Corp. (NASDAQ: AGCO) had its â€œoutperformâ€ rating re-affirmed by analysts at Zacks. They now have a $52.00 price target on the stock.

View the full article

#11 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 12 May 2012 - 01:12 AM

Oppenheimer Gives Market Perform Rating to Aastrom Biosciences (ASTM)
Junction Report - 3 hours ago

Oppenheimer Reiterates Perform Rating for Aastrom Biosciences - Benzinga

View the full article

#12 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 11:29 PM

Oppenheimer Reiterates Perform Rating for Aastrom Biosciences
Benzinga - May 11, 2012

By Dwight Einhorn In a company update published earlier today, Oppenheimer Holdings reiterated its Perform rating for Aastrom Biosciences, Inc. (NASDAQ: ASTM), but did not name a price target.

View the full article

#13 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 11:29 PM

Oppenheimer Reiterates Perform Rating for Aastrom Biosciences
Benzinga - May 11, 2012

By Dwight Einhorn In a company update published earlier today, Oppenheimer Holdings reiterated its Perform rating for Aastrom Biosciences, Inc. (NASDAQ: ASTM), but did not name a price target.

View the full article

#14 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 11:29 PM

Oppenheimer Reiterates Perform Rating for Aastrom Biosciences
Benzinga - May 11, 2012

By Dwight Einhorn In a company update published earlier today, Oppenheimer Holdings reiterated its Perform rating for Aastrom Biosciences, Inc. (NASDAQ: ASTM), but did not name a price target.

View the full article

#15 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 11 May 2012 - 11:29 PM

Oppenheimer Reiterates Perform Rating for Aastrom Biosciences
Benzinga - May 11, 2012

By Dwight Einhorn In a company update published earlier today, Oppenheimer Holdings reiterated its Perform rating for Aastrom Biosciences, Inc. (NASDAQ: ASTM), but did not name a price target.

View the full article

#16 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 14 May 2012 - 12:34 PM

Osiris Therapeutics (NASDAQ:OSIR) Posts $1.3 Million Loss in First Quarter ...
PT News - 14 minutes ago

Osiris Therapeutics, Inc (NASDAQ:OSIR) announced on Friday a loss of $1.3 million or $0.04 a share in the first-quarter, evaluated against a profit of $4.0 million or $0.12 a share in the similar quarter previous year.

View the full article

#17 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 14 May 2012 - 12:47 PM

HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and ...
MarketWatch (press release) - 1 hour ago

ALAMEDA, Calif., May 14, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) announced today the publication of a scientific paper demonstrating the effectiveness of HyStem®-C in the transplantation of heart muscle-derived cells in an animal model ...

HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and ... - Genetic Engineering News

View the full article

#18 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 14 May 2012 - 12:34 PM

Osiris Therapeutics (NASDAQ:OSIR) Posts $1.3 Million Loss in First Quarter ...
PT News - 3 hours ago

View the full article

#19 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 12 May 2012 - 03:11 AM

Equities Research Analysts' Ratings Reiterations for May, 11st (AGCO, ARX ...
Junction Report - May 12, 2012

AGCO Corp. (NASDAQ: AGCO) had its â€œoutperformâ€ rating re-affirmed by analysts at Zacks. They now have a $52.00 price target on the stock.

View the full article

#20 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 15 May 2012 - 01:15 AM

Furiex Gets Product Rights for Priligy; Celsion Announces Resubmission of ...
BioMedReports (subscription) - 3 hours ago

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 14, 2012.

View the full article

#21 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 14 May 2012 - 01:08 PM

HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and ...
SunHerald.com - 15 hours ago

ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) announced today the publication of a scientific paper demonstrating the effectiveness of HyStem ® -C in the transplantation of heart muscle-derived cells in an animal model of heart disease.

View the full article

#22 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 14 May 2012 - 12:48 PM

HyStem-C Demonstrated Effective when Formulated with Human Heart Cells and ...
Benzinga - May 14, 2012

By Eddie Staley BioTime, Inc. (NYSE: BTX) announced today the publication of a scientific paper demonstrating the effectiveness of HyStem®-C in the transplantation of heart muscle-derived cells in an animal model of heart disease.

View the full article

#23 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 03:05 AM

Investment Analysts' New Coverage for May, 15th (ASTM, CPA, IMUC, MPAA, NCT ...
Junction Report - 14 minutes ago

Aastrom Biosciences Inc (NASDAQ: ASTM) is now covered by analysts at Ascendiant Capital Markets. They set a â€œstrong-buyâ€ rating on the stock.

View the full article

#24 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 01:38 PM

Upgrades & Downgrades: Bulls Run on Dunkin'
Minyanville.com - 13 minutes ago

By Justin Sharon May 16, 2012 9:30 am MINYANVILLE ORIGINAL Zeus, the Greek god of thunder, was angry yesterday, as France's freshly sworn-in president can attest to after a pitch-perfect metaphor for Europe's fiscal crisis.

View the full article

#25 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 11:40 AM

Ascendiant Capital Starts Aastrom Biosciences (ASTM) at Strong Buy; Leading ...
StreetInsider.com (subscription) - 2 hours ago

Analyst, Keay Nakae, said, "We believe that Aastrom is one of the best positioned, pure play regenerative medicine companies.

View the full article

#26 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 02:56 PM

HyStem®-C Demonstrated Effective when Formulated with Human Heart Cells and ...
BiotechStockTrader.com - 25 minutes ago

BioTime, Inc. (NYSE MKT: BTX) announced today the publication of a scientific paper demonstrating the effectiveness of HyStem ® -C in the transplantation of heart muscle-derived cells in an animal model of heart disease.

View the full article

#27 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 05:06 PM

Ascendiant Capital Markets Analysts Begin Coverage on Aastrom Biosciences (ASTM)
Movie News Guide (blog) - 15 minutes ago

Equities researchers at Ascendiant Capital Markets assumed coverage on shares of Aastrom Biosciences (NASDAQ: ASTM) in a report issued on Tuesday.

Ascendiant Capital Starts Aastrom Biosciences (ASTM) at Strong Buy; Leading ... - StreetInsider.com (subscription)

View the full article

#28 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 01:38 PM

Upgrades & Downgrades: Bulls Run on Dunkin'
Minyanville.com - 3 hours ago

View the full article

#29 ImmInst

Topic Starter
Admin, Director robot
2,350 posts
72 ₮

Posted 16 May 2012 - 05:33 PM

RegMed Competitive and Market Intelligence 5/16/12, An analyst is an â€œexpert ...
Proactive Investors USA & Canada - 2 hours ago

Mid-Day Market Commentary: Some RegMed stocks opened higher (ASTM and OSIR) as others struggled to gain footage â€¦ in choppy trading Wednesday, as economic reports â€¦ get better.

View the full article